Pilot Study on the Use of Sirolimus to Treat Chronic Allograft Nephropathy in Children After Kidney Transplant
PHASE4CompletedINTERVENTIONAL
Enrollment
40
Participants
Timeline
Start Date
March 31, 2004
Study Completion Date
October 31, 2008
Conditions
Kidney Transplantation
Interventions
DRUG
sirolimus
Trial Locations (1)
R3A 1S1
Children's Hospital, Winnipeg
All Listed Sponsors
collaborator
Wyeth is now a wholly owned subsidiary of Pfizer
INDUSTRY
lead
University of Manitoba
OTHER
NCT00188955 - Pilot Study on the Use of Sirolimus to Treat Chronic Allograft Nephropathy in Children After Kidney Transplant | Biotech Hunter | Biotech Hunter